H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census population 577,222. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Milwaukee clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Milwaukee storefront.
Chronic Wound Treatment That Works in Milwaukee, WI for clinics & physicians. Effective chronic wound trea… Compliance support & pricing — contact Hawk Medical.
Milwaukee is a city of 500k–1M (577,222 Census). CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Adult arthritis here is 23.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Chronic Wound Treatment That Works notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Milwaukee we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure.
Vendor consolidation is boring on purpose: one account, IFUs filed, J6 articles mapped. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 14.7% of adults — 2.7 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Milwaukee trial.
No. They are B2B distribution pages for licensed providers. Patients in Milwaukee should speak with their clinician, not use a distributor URL as care instructions.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Wisconsin compliance risk.
If you operate in Wisconsin and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Milwaukee tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Milwaukee, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Milwaukee is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Milwaukee — 2.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Milwaukee. Useful for joint-program math; still needs a diagnosis and privileging.
No Milwaukee storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.